News

Discover how Lactobacillus plantarum F3-2 may support weight management by regulating gut microbiota, increasing SCFAs, and reducing fat accumulation through the GPR43–PPARγ pathway.

Recently, Bioyitech was officially accepted as a member of the Sports Nutrition Professional Committee of the Shanghai Health Products Association. This recognition from the Association not only affirms our long-term commitment to the microbiome field, but also marks a solid step forward on Bioyitech’s path of high-quality development.

From May 5 to 7, 2026, local time, Vitafoods Europe, the world’s most influential event in nutrition and health, grandly opened in Barcelona, Spain. At this industry bellwether gathering more than 1,600 top companies from around the globe, Zhongchuang Yike (Shanghai) Biotechnology Co., Ltd. made a striking appearance with a clear positioning – "Metabolic Health Microbiome Solution Expert" – showcasing its end-to-end strength from proprietary strain screening to final application.

In recent years, the link between gut health and weight management has drawn increasing attention. Probiotics and prebiotics, often called the “golden duo” for gut regulation — can they really help us slim down? A recent study from the College of Food Science and Engineering at Ocean University of China provides a clear answer: the synbiotic combination of Lactobacillus plantarum F3-2 and manno-oligosaccharides (MOS) tackles obesity at its gut-root cause, and works even more powerfully than prebiotics alone.

Recently, the group standard *"Efficacy Evaluation of Probiotics in Obesity and Metabolic Syndrome" (T/FDSA 0155—2026)* was officially implemented. Developed under the leadership of a national-level industry authority, this standard standardizes the efficacy validation, evaluation dimensions, and judgment criteria for related products. It establishes, for the first time in China, a foundational system for evaluating the metabolic health efficacy of probiotics, filling an industry gap and laying the cornerstone for the standardized and scientific development of this specialized field.

When "comprehensive health" evolves from a fleeting trend into the defining ethos of our era, and "scientific nutrition" becomes the core demand of consumers, the boundaries between the food and health industries are being redrawn. We now stand at a brand-new starting point—a "great era of nutrition" driven by scientific evidence and centered on precision nutrition. 

Osteoporosis is a systemic skeletal disease characterized by reduced bone mass and deterioration of the bone’s microarchitecture. It makes bones more fragile and prone to fracture even under minor external force. It is caused by multiple factors (such as age, gender, nutrition, lifestyle, etc.) that lead to abnormal bone metabolism, in which the rate of bone resorption exceeds that of bone formation, resulting in reduced bone quality and strength.

Bioyitech, as one of the first enterprises, has been invited to participate in the pilot and development of the State Administration for Market Regulation's "Internet + AI Regulation" Platform Interface and Data Collection Specifications. This recognition affirms its "Smart Factory" achievements at the national level and officially positions the company among the industry standard-setters, establishing a new benchmark of "AI + Food Safety" for the probiotics industry.

Food Ingredients China is the world’s largest and most international professional exhibition for the food additives and ingredients industry.It brings together all top international giants such as Cargill, IFF, and DSM-Firmenich, making it the preferred platform for companies to launch new products.Through the Food Industry Academician Forum and the China-International Regulations and Standards Forum,” it establishes a high-end and professional exchange system.

The 28th China International Food Additives and Ingredients Exhibition (FIC 2026) successfully concluded from March 17 to 19, 2026, at the National Exhibition and Convention Center (Hongqiao) in Shanghai.